ERBB2 and breast cancer: Loss of nuclear RB1CC1 [RB1CC1(−)] correlated significantly with negative PR expression (p = 0.0003) and with a triple-negative [ER(−), PR(−) and HER2(−)] phenotype of breast cancer (p = 0.0003).